US 9499868
Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate
granted A61KA61K38/02A61K38/16
Quick answer
US patent 9499868 (Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/02, A61K38/16, A61K45/06, A61P